Vital Signs - The Rapid Rise of Point-of-care Testing in Physician Office Labs

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on December 18, 2006, provides a strategic overview of the rise in use of point-of-care testing (POCT) and physician office laboratories. Additionally, an emerging company profile is provided for Abaxis Inc., a leader in the development of POCT blood analyzers for the medical and veterinary markets. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of December 4 - December 8, 2006.

Table of Contents

Vital Signs - The Rapid Rise of Point-of-care Testing in Physician Office LabsVital Signs: 18 December 2006This week's issue:




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.